Biodexa Pharmaceuticals plc American Depositary (BDRX) Live Share Price, Invest From India

Biodexa Pharmaceuticals plc American Depositary Stock Performance

as on July 11, 2026 at 2:15 pm IST

Day's Low
$2.40
Day's Price Range
$2.49
$2.49
3.61%
Downside
52 Week's Low
52 Week's High
$2.40
52-Week Price Range
$66.50
$2.49
3.61%
Downside
2570.68%
Upside

Biodexa Pharmaceuticals plc American Depositary share price movements today

Previous Close: $2.59
Open: $2.47
Volume: 379.8K
Day's Low - High: $2.40 - $2.49
52 Week Low - High: $2.40 - $66.50

Biodexa Pharmaceuticals plc American Depositary Historical Returns

1 Month Return: -19.21 %
3 Month Return: -25.89 %
1 Year Return: -94.3 %
3 Year Return: -99.97 %
5 Year Return: 0 %

Biodexa Pharmaceuticals plc American Depositary Stock Fundamentals & Key Indicators

Check Biodexa Pharmaceuticals plc American Depositary market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-8.6M

Revenue (TTM)

83.0K

Profit Margin

0.00%

Return On Equity TTM

-64.72%

Biodexa Pharmaceuticals plc American Depositary vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biodexa Pharmaceuticals plc American Depositary with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Biodexa Pharmaceuticals plc American Depositary	BUY	$2.1M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$41.8B	69.04%	81.24	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$126.0B	144.95%	29.59	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.0B	14.49%	16.18	29.65%	0.54%

Stock Returns calculator for Biodexa Pharmaceuticals plc American Depositary Stock including INR - Dollar returns

The Biodexa Pharmaceuticals plc American Depositary stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Biodexa Pharmaceuticals plc American Depositary investment value today

Current value as on today

₹6,332

Returns

-₹93,668

(-93.67%)

Returns from Biodexa Pharmaceuticals plc American Depositary Stock

-₹94,302 (-94.3%)

Dollar Impact

₹634 (+0.63%)

Analyst Recommendation on Biodexa Pharmaceuticals plc American Depositary Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Biodexa Pharmaceuticals plc American Depositary. Average target price of $10.13

Biodexa Pharmaceuticals plc American Depositary Share Price Target

Get share price movements and forecasts by analysts on Biodexa Pharmaceuticals plc American Depositary.

What analysts predicted

75.42%UPSIDE

Target Price

$10.13

Current Price

$2.49

Analyzed by

7 Analysts

Target

$10.13

Biodexa Pharmaceuticals plc American Depositary target price $10.13, a slight upside of 75.42% compared to current price of $2.49. According to 7 analysts rating.

Indian Investors' Interest in Biodexa Pharmaceuticals plc American Depositary Stock

Search interest for Biodexa Pharmaceuticals plc American Depositary Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 12, 2026 to July 12, 2026

Change:28% versus previous 30 day period

Biodexa Pharmaceuticals plc American Depositary Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Total Revenue	0	0	0	0
Gross Profit	-1	-2	-1	-2
Operating Income	-2	-4	-1	-3
EBITDA	-2	-4	-1	-2
Interest Expense	-	-	-	-
Depreciation	-	-	-	-
Income Before Tax	-1	-3	-1	-3
Income Tax Expense	0	0	0	0
Net Income	-2	-4	-1	-3
Net Profit Margin	-1197.32%	-1197.32%	-4230.12%	-4230.12%

Biodexa Pharmaceuticals plc American Depositary Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	0	1	0	0	0	0	0	-	-
Gross Profit	-6	-7	-7	-9	-7	-5	-5	-4	-6	0
Operating Income	-9	-11	-11	-11	-23	-6	-8	-8	-9	-8
EBITDA	-5	-10	-10	-9	-22	-5	-8	-7	-9	-8
Interest Expense	-	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	1	1	0	0	0	0	0
Income Before Tax	-8	-12	-12	-10	-23	-6	-8	-7	-5	-6
Income Tax Expense	-2	-1	-2	-1	-1	0	0	0	0	0
Net Income	-6	-11	-10	-13	-29	-7	-9	-8	-7	-6
Net Profit Margin	-465.68%	-1183.52%	-534.98%	-1496.29%	-6469.10%	-944.64%	-1095.28%	-1858.01%	0.00%	0.00%

Biodexa Pharmaceuticals plc American Depositary Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024	Mar 2025	Jun 2025	Dec 2025
Net Income	-3	-1	-3	-1	-3	-2	-2	-3	-2
Operating Cash Flow	-3	-1	-2	-2	-4	-7	-7	-3	-2
Investing Cash Flow	0	-	0	-	0	0	0	0	0
Financing Cash Flow	6	1	3	2	4	3	4	5	7
Change in Cash	1	0	0	0	5	-5	-3	4	4

Biodexa Pharmaceuticals plc American Depositary Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-15	-10	-22	-5	-7	-7	-5	-6
Operating Cash Flow	-12	-13	-6	-9	-6	-7	-6	-12	-5
Investing Cash Flow	-1	9	-3	2	0	0	0	0	0
Financing Cash Flow	10	-6	18	3	8	0	10	8	12
Change in Cash	-4	-10	8	-3	2	-7	3	-4	6

Global Institutional Holdings in Biodexa Pharmaceuticals plc American Depositary

Funds	Holdings
UBS Group AG	0%
Hilton Head Capital Partners, LLC	0%
Rhumbline Advisers	0%
GAMMA Investing LLC	0%
HRT FINANCIAL LLC	0%

See all

Insights on Biodexa Pharmaceuticals plc American Depositary

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.80M → -2.56M (in $), with an average increase of 48.6% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 41.5K → 83.0K (in $), with an average increase of 50.0% per quarter
NO EFFECT
Against Peers
In the last 3 years, Biodexa Pharmaceuticals plc American Depositary Shs has experienced a drawdown of -100.0%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 95.0%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.3% return, outperforming this stock by 113.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, BDRX stock has moved down by -11.9%

About Biodexa Pharmaceuticals plc American Depositary

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer. Its lead product candidate, Tolimidone, is a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of recurrent glioblastoma, diffuse midline glioma, and medulloblastoma; and MTX240, for the treatment of gastrointestinal stromal tumors. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release therapeutics; MidaSolve, nanotechnology used to dissolve insoluble drugs so that they can be administered in liquid form directly and locally into tumours; and MidaCore, a gold nanoparticle used for targeting sites of disease. It has collaboration agreements with Janssen and Melior. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Organisation	Biodexa Pharmaceuticals plc American Depositary
Headquarters	1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ
Industry	Biotechnology
CEO	Mr. Stephen Anthony Stamp
E-voting on shares	Click here to vote

Key Management of Biodexa Pharmaceuticals plc American Depositary

Name	Title
Dr. Gary A. Shangold CPI, FACOG, M.D.	Chief Medical Officer
Ms. Noreen Bhatti	Vice President of Clinical Operations
Mr. Stephen Anthony Stamp	CEO & Director
Ms. Fiona Mary Powell	Company Secretary, CFO & Director
Dr. Daniel Palmer MBA, Ph.D.	Vice President of Technology
Mr. Steve Ellul	Chief Business Officer

FAQs

What is Biodexa Pharmaceuticals plc American Depositary share price today?

Biodexa Pharmaceuticals plc American Depositary share price today is $2.49 as on July 11, 2026 at 8:45 am IST at the close of the market. Biodexa Pharmaceuticals plc American Depositary share today touched a day high of $2.49 and a low of $2.40.

What is the 52 week high and 52 week low for Biodexa Pharmaceuticals plc American Depositary share?

Biodexa Pharmaceuticals plc American Depositary share touched a 52 week high of $66.50 on July 14, 2025 and a 52 week low of $2.40 on July 10, 2026. Biodexa Pharmaceuticals plc American Depositary stock price today i.e. July 11, 2026 at 8:45 am IST is closed at $2.49,which is 96.26% down from its 52 week high and 3.75% up from its 52 week low.

What is Biodexa Pharmaceuticals plc American Depositary's market capitalisation today?

Biodexa Pharmaceuticals plc American Depositary market capitalisation is $0.00T as on July 11, 2026 at 8:45 am IST.

How to invest in Biodexa Pharmaceuticals plc American Depositary Stock (BDRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biodexa Pharmaceuticals plc American Depositary on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biodexa Pharmaceuticals plc American Depositary Shares that will get you 0.6024 shares as per Biodexa Pharmaceuticals plc American Depositary share price of $2.49 per share as on July 11, 2026 at 8:45 am IST.

What is the minimum amount required to buy Biodexa Pharmaceuticals plc American Depositary Stock (BDRX) from India?

Indian investors can start investing in Biodexa Pharmaceuticals plc American Depositary (BDRX) shares with as little as ₹95.37 or $1 (as of July 12, 2026 at 7:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.70 in Biodexa Pharmaceuticals plc American Depositary stock (as per the Rupee-Dollar exchange rate as on July 12, 2026 at 7:37 pm IST). Based on Biodexa Pharmaceuticals plc American Depositary share’s latest price of $2.49 as on July 11, 2026 at 8:45 am IST, you will get 4.0161 shares of Biodexa Pharmaceuticals plc American Depositary. Learn more about fractional shares .